Skip to main content
Premium Trial:

Request an Annual Quote

Not So Secret

Just how private is your DNA, asks an article in Salon. The story covers the pros and cons of inadvertently making your DNA public by buying personal genome services, for instance, and how your code might eventually be misused. "The promise of these tests includes drugs that may someday be tailored to treat your illnesses," the story says. "The peril is that your personal data could circulate more widely than you expect." Blaine Bettinger, who is a customer of 23andMe, was interviewed, and he's a bit more optimistic about data handling. "They have every incentive to keep information private," he says. "A security breach would be devastating for those companies."

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.